In 2021, Teva's Spanish subsidiary had a turnover of around 412 million euros in a global context of slowing turnover, which in 2022 fell by 6%....
The second Spanish biotech company most endorsed by investors last year was the Valencian Arthex Biotech, protagonist of a round of 42 million. Specialized in therapies...
The presentation of the results was scheduled for the end of February, but Grifols wants to move forward so that the situation is not unsustainable for...
The distribution model in Italy is made up of manufacturing industries and pharmacies which is essentially based on the classic customer-supplier relationship or on the establishment...
A week ago, BioNTech presented its billing forecasts for 2024, with the aim of reaching €3 billion. The figure represents a significant decrease in value compared...
Novartis CEO said that the pharmaceutical company's strategy involves not exceeding acquisitions of more than $5 billion. The agreement with Cytokinetics meant a larger investment, since,...
XRHealth has offices in Barcelona and Sydney, as well as an Innovation and Development center in Tel Aviv, and has sixty employees. The American company offers...
The intraday minimum was marked at 10:31 a.m., with 8.22 euros, after the stock spent an hour and a half in a volatility auction trying to...
In June 2023, the HumanITCare closed a collaboration agreement with Clínicas Mi to accompany cancer patients throughout their treatment, from any location, 24 hours a day,...
Atrys advances in its purpose of promoting the company's organic growth in its three strategic areas. The company achieved a turnover of €169.5 million in the...